Chronic inflammatory demyelinating polyneuropathy is a rare, acquired, symmetrical, sensory motor
neuropathy usually, chronic form of guillain barre syndrome. The standard therapy options include intravenous immunoglobulin and plasmapharesis, corticosteroids, azathioprine, cyclophosphamide, etanercept, mycophenolate mofetil, interferon alpha 2a and tacrolimus. Current ones are interferon beta 1a, rituximab, and high dose cyclophosphamide.